Stock is down by +/- $3 avg today. I see it got a "sell" rating. What's the inside scoop? Did MNK-795/Xartemis XR not get approved?
Good run up since Jan 7. Just settling. Downgrade by analysts because imaging dragging profits down. Still trouble with Netherlands reactor. Fears of generic competition for old Pennsaid starting Apr 1. Exalgo generic soon. Unsettled period. Once XXR gets out, mood will improve.
Stock holder. Day trader. Last I heard FDA labeling issue with XXR. Just trying to make $ like you guys.